Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
B.memory.activated: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 3,376 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TCL1A levels | PROLV002002 | 80.22 | Protein levels | B / plasma cell | 115 | 2 | 6 | 13 | |
| 2 | FCRL1 levels | PROLV000783 | 79.63 | Protein levels | B / plasma cell | 101 | 2 | 7 | 15 | |
| 3 | PARP1/TCL1A ratio | PRORT001622 | 75.04 | Protein ratios | B / plasma cell | 44 | 2 | 5 | 17 | |
| 4 | FCRL2 levels | PROLV000784 | 74.87 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 5 | CD22 levels | PROLV000320 | 72.73 | Protein levels | B / plasma cell | 103 | 2 | 9 | 20 | |
| 6 | IL5RA levels | PROLV001076 | 70.51 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 7 | CD27/TNFRSF13B ratio | PRORT000418 | 67.47 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 8 | FCRL5/LY96 ratio | PRORT001134 | 66.83 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 9 | FCER2 levels | PROLV000777 | 65.77 | Protein levels | B / plasma cell | 112 | 3 | 9 | 24 | |
| 10 | FCER2/TREML2 ratio | PRORT001123 | 62.99 | Protein ratios | B / plasma cell | 13 | 3 | 7 | 12 | |
| 11 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 61.16 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 12 | TNFSF13B levels | PROLV002079 | 57.81 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 13 | CD27/TNFRSF9 ratio | PRORT000419 | 57.14 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 14 | JCHAIN levels | PROLV001126 | 55.38 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 15 | TCL1A/TNFRSF13C ratio | PRORT001829 | 55.32 | Protein ratios | B / plasma cell | 23 | 2 | 14 | 31 | |
| 16 | CD72 levels | PROLV000354 | 54.36 | Protein levels | B / plasma cell | 84 | 2 | 12 | 31 | |
| 17 | TNFRSF13C levels | PROLV002064 | 52.46 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 18 | FCER2/FCRL1 ratio | PRORT001120 | 51.91 | Protein ratios | B / plasma cell | 37 | 3 | 9 | 14 | |
| 19 | TNFRSF13B levels | PROLV002063 | 49.36 | Protein levels | B / plasma cell | 55 | 2 | 8 | 14 | |
| 20 | FCRL5/TNFRSF13B ratio | PRORT001136 | 48.82 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 21 | Non-albumin protein levels | PROLV001459 | 48.26 | Protein levels | B / plasma cell | 766 | 3 | 12 | 26 | |
| 22 | Monoclonal gammopathy | HEMAT000041 | 46.13 | Hematologic | B / plasma cell | 2 | 4 | 15 | 28 | |
| 23 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 45.33 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 24 | FCER2/TCL1A ratio | PRORT001121 | 43.61 | Protein ratios | B / plasma cell | 38 | 2 | 8 | 22 | |
| 25 | ALB/Globulin ratio | PRORT000067 | 42.03 | Protein ratios | B / plasma cell | 721 | 2 | 16 | 39 | |
| 26 | CD22/TCL1A ratio | PRORT000404 | 41.85 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 27 | ZNRD2 levels | PROLV002213 | 41.44 | Protein levels | B / plasma cell | 62 | 2 | 14 | 25 | |
| 28 | Ornithine metabolites | METAB000011 | 40.57 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 29 | FCER2/TNFRSF9 ratio | PRORT001122 | 40.00 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 30 | CD5L levels | PROLV000348 | 39.72 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 31 | IL18RAP levels | PROLV001057 | 39.22 | Protein levels | B / plasma cell | 20 | 2 | 5 | 6 | |
| 32 | FCRL2/TNFRSF13B ratio | PRORT001132 | 38.58 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 33 | CR2/TNFRSF13B ratio | PRORT000738 | 38.30 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 34 | FCRL1/TREML2 ratio | PRORT001128 | 38.25 | Protein ratios | B / plasma cell | 34 | 2 | 6 | 24 | |
| 35 | INPP5J levels | PROLV001090 | 38.18 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 36 | FCRL1/TCL1A ratio | PRORT001126 | 38.09 | Protein ratios | B / plasma cell | 21 | 3 | 14 | 38 | |
| 37 | TNFRSF17 levels | PROLV002066 | 37.29 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 38 | CD22/SEMA7A ratio | PRORT000403 | 37.15 | Protein ratios | B / plasma cell | 54 | 3 | 10 | 26 | |
| 39 | Heme malignancy, Lymphoid | MALIG000043 | 35.76 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 40 | TXNDC15 levels | PROLV002124 | 35.54 | Protein levels | B / plasma cell | 86 | 4 | 19 | 38 | |
| 41 | Heme malignancy, Plasma cell | MALIG000046 | 35.13 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 42 | SLAMF1 levels | PROLV001875 | 34.78 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 43 | FCRL1/TNFRSF13C ratio | PRORT001127 | 31.69 | Protein ratios | B / plasma cell | 39 | 3 | 7 | 10 | |
| 44 | UGDH levels | PROLV002138 | 31.41 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 45 | CD79B/TNFRSF13B ratio | PRORT000513 | 31.36 | Protein ratios | B / plasma cell | 14 | 2 | 5 | 6 | |
| 46 | CD27/NBL1 ratio | PRORT000415 | 30.84 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 47 | IL5RA/TNFRSF13B ratio | PRORT001352 | 29.73 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 48 | SEPTIN3 levels | PROLV001813 | 29.63 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 49 | MZB1/TNFRSF13B ratio | PRORT001568 | 29.56 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 50 | NINJ1 levels | PROLV001406 | 29.30 | Protein levels | B / plasma cell | 21 | 2 | 10 | 19 | |
| 51 | FCRL2/LY9 ratio | PRORT001130 | 28.95 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 52 | CD27 levels | PROLV000324 | 28.83 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 53 | LILRB1 levels | PROLV001213 | 27.97 | Protein levels | B / plasma cell | 214 | 5 | 14 | 33 | |
| 54 | FCRL5/ICAM3 ratio | PRORT001133 | 27.88 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 55 | CD22/FCRL1 ratio | PRORT000401 | 27.18 | Protein ratios | B / plasma cell | 100 | 2 | 15 | 25 | |
| 56 | CR2 levels | PROLV000514 | 26.74 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 57 | Pain, limb | MSKEL000037 | 26.08 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 58 | FCRL2/SEMA7A ratio | PRORT001131 | 25.98 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 59 | TP53BP1 levels | PROLV002090 | 25.79 | Protein levels | B / plasma cell | 66 | 2 | 10 | 28 | |
| 60 | BLNK levels | PROLV000200 | 25.44 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 61 | CD27/TGFBR2 ratio | PRORT000417 | 25.36 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 62 | Plasma protein metabolism disorder | METBL000029 | 25.26 | Metabolic | Hepatocyte | 26 | 2 | 6 | 24 | |
| 63 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 24.63 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 64 | Gut microbial abundance, Bifidobacterium | GASTR000019 | 24.59 | Gastrointestinal | B / plasma cell | 0 | 3 | 6 | 20 | |
| 65 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 24.57 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 66 | CD79B/TNFRSF4 ratio | PRORT000514 | 24.50 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 67 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 24.43 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 68 | KIF22 levels | PROLV001139 | 24.20 | Protein levels | B / plasma cell | 35 | 2 | 5 | 11 | |
| 69 | PLXNA4/USP8 ratio | PRORT001688 | 24.10 | Protein ratios | B / plasma cell | 5 | 4 | 8 | 32 | |
| 70 | ICAM3/TNFRSF13B ratio | PRORT001329 | 23.76 | Protein ratios | B / plasma cell | 40 | 1 | 7 | 6 | |
| 71 | CD22/FOLR2 ratio | PRORT000402 | 23.70 | Protein ratios | B / plasma cell | 34 | 4 | 11 | 16 | |
| 72 | MBL2 levels | PROLV001282 | 23.45 | Protein levels | B / plasma cell | 15 | 2 | 7 | 23 | |
| 73 | Pre-existing hypertension, pregnancy | VASCU000044 | 23.29 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 74 | PEAR1/TREML2 ratio | PRORT001661 | 23.17 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 12 | |
| 75 | S100A11/S100A12 ratio | PRORT001753 | 22.91 | Protein ratios | B / plasma cell | 25 | 4 | 17 | 38 | |
| 76 | CD27/DLL1 ratio | PRORT000412 | 22.69 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 77 | TRAF3 levels | PROLV002100 | 22.60 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 78 | CD83/IL12A_IL12B ratio | PRORT000516 | 22.52 | Protein ratios | B / plasma cell | 66 | 3 | 11 | 16 | |
| 79 | GART levels | PROLV000854 | 22.46 | Protein levels | B / plasma cell | 12 | 5 | 10 | 12 | |
| 80 | Severe mental illness | PSYCH000017 | 22.26 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 81 | MYCT1 levels | PROLV001357 | 22.03 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 82 | PDCD1/TNFRSF8 ratio | PRORT001630 | 21.57 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 83 | CRYBB2 levels | PROLV000533 | 21.52 | Protein levels | B / plasma cell | 4 | 2 | 6 | 14 | |
| 84 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 21.51 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 85 | Systemic lupus erythematosus, SLE | IMMUN000020 | 21.14 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 86 | QPCT/RNASET2 ratio | PRORT001726 | 20.83 | Protein ratios | B / plasma cell | 68 | 5 | 12 | 31 | |
| 87 | IL2RA levels | PROLV001069 | 20.71 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 88 | ZNF830 levels | PROLV002212 | 20.26 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 89 | CD22/FCER2 ratio | PRORT000400 | 20.16 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 8 | |
| 90 | GZMA/IL12A_IL12B ratio | PRORT001259 | 20.01 | Protein ratios | B / plasma cell | 51 | 3 | 7 | 8 | |
| 91 | Soft tissue disorder | MSKEL000069 | 19.97 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 92 | Heme malignancy, Leukaemia | MALIG000042 | 19.65 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 93 | Liver fibrosis and cirrhosis | HPBIL000007 | 19.63 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 94 | LY96 levels | PROLV001250 | 19.61 | Protein levels | B / plasma cell | 122 | 4 | 12 | 23 | |
| 95 | CD27/CD79B ratio | PRORT000411 | 19.59 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 96 | Primary biliary cholangitis, PBC | IMMUN000017 | 19.41 | Immunologic | Lymphocyte | 91 | 3 | 13 | 9 | |
| 97 | THY1 levels | PROLV002031 | 19.39 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 98 | IGLC2 levels | PROLV001035 | 19.15 | Protein levels | B / plasma cell | 51 | 3 | 15 | 23 | |
| 99 | FOLR2 levels | PROLV000823 | 19.13 | Protein levels | Myeloid | 134 | 3 | 10 | 11 | |
| 100 | CRTAP levels | PROLV000531 | 18.78 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 101 | FCER1A levels | PROLV000776 | 18.31 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 102 | FCGR2A levels | PROLV000778 | 18.07 | Protein levels | Myeloid | 62 | 3 | 9 | 13 | |
| 103 | PRCP levels | PROLV001624 | 17.80 | Protein levels | Myeloid | 18 | 3 | 10 | 18 | |
| 104 | FCRL5 levels | PROLV000786 | 17.40 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 105 | PGR levels | PROLV001548 | 17.31 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 106 | ELOA/POLR2F ratio | PRORT001016 | 17.23 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 107 | CD79B/CKAP4 ratio | PRORT000509 | 17.16 | Protein ratios | B / plasma cell | 35 | 2 | 8 | 8 | |
| 108 | CD79B/FCRL1 ratio | PRORT000510 | 17.12 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 109 | CD302/IL12A_IL12B ratio | PRORT000438 | 16.65 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 110 | Glycan trait | METAB000054 | 16.57 | Metabolites | B / plasma cell | 70 | 2 | 6 | 26 | |
| 111 | ATP5IF1/LYN ratio | PRORT000159 | 16.55 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 112 | Hypothyroidism, secondary | ENDOC000015 | 16.54 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 113 | Middle ear and mastoid disorder | AUDIO000016 | 16.37 | Auditory | B / plasma cell | 51 | 4 | 14 | 30 | |
| 114 | EDA2R levels | PROLV000673 | 16.34 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 115 | PCSK7 levels | PROLV001511 | 16.22 | Protein levels | B / plasma cell | 5 | 3 | 9 | 15 | |
| 116 | CCL5/TACC3 ratio | PRORT000359 | 16.07 | Protein ratios | Myeloid | 3 | 7 | 17 | 29 | |
| 117 | BSG/IL12A_IL12B ratio | PRORT000247 | 16.00 | Protein ratios | B / plasma cell | 54 | 3 | 7 | 14 | |
| 118 | GFRA2/IL12A_IL12B ratio | PRORT001210 | 15.86 | Protein ratios | B / plasma cell | 52 | 3 | 12 | 22 | |
| 119 | IL12A_IL12B/LAG3 ratio | PRORT001341 | 15.86 | Protein ratios | B / plasma cell | 67 | 3 | 7 | 9 | |
| 120 | DEFA1_DEFA1B/LCN2 ratio | PRORT000885 | 15.83 | Protein ratios | Myeloid | 58 | 4 | 9 | 16 | |
| 121 | CRTAM/LY9 ratio | PRORT000772 | 15.72 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 122 | Mood disorder | PSYCH000028 | 15.64 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 123 | CD27/FCRL5 ratio | PRORT000413 | 15.50 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 124 | Occupational attainment | SOCIO000007 | 15.28 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 125 | CA1/CA3 ratio | PRORT000268 | 15.17 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 126 | EPHB6/VWC2 ratio | PRORT001039 | 14.96 | Protein ratios | B / plasma cell | 2 | 4 | 11 | 20 | |
| 127 | ADH4/SCLY ratio | PRORT000043 | 14.85 | Protein ratios | Hepatocyte | 18 | 4 | 15 | 30 | |
| 128 | CDKN1A/TACC3 ratio | PRORT000572 | 14.73 | Protein ratios | B / plasma cell | 20 | 4 | 12 | 29 | |
| 129 | Primary sclerosing cholangitis, PSC | IMMUN000018 | 14.64 | Immunologic | B / plasma cell | 90 | 3 | 12 | 15 | |
| 130 | CDKN2D/TACC3 ratio | PRORT000580 | 14.57 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 131 | SEPTIN8 levels | PROLV001814 | 14.45 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 132 | Medication, dermatologic | DERMA000024 | 14.43 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 133 | Lymphocyte | HEMAT000024 | 14.13 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 134 | CD38/IL12A_IL12B ratio | PRORT000439 | 13.93 | Protein ratios | Myeloid | 70 | 3 | 7 | 11 | |
| 135 | CLPP/DECR1 ratio | PRORT000672 | 13.85 | Protein ratios | B / plasma cell | 0 | 4 | 9 | 10 | |
| 136 | Physical activity, none | BEHAV000005 | 13.57 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 137 | CEACAM8/MMP9 ratio | PRORT000587 | 13.55 | Protein ratios | Myeloid | 32 | 2 | 9 | 12 | |
| 138 | White blood cell disorder | HEMAT000019 | 13.54 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 139 | Total protein levels | PROLV002131 | 13.45 | Protein levels | Myeloid | 897 | 4 | 12 | 26 | |
| 140 | C2 levels | PROLV000230 | 13.28 | Protein levels | B / plasma cell | 63 | 2 | 10 | 16 | |
| 141 | SPINT1/SUSD2 ratio | PRORT001810 | 13.25 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 7 | |
| 142 | Educational attainment, none | SOCIO000001 | 13.25 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 143 | PDGFRB levels | PROLV001526 | 13.21 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 144 | CD74 levels | PROLV000355 | 13.05 | Protein levels | B / plasma cell | 145 | 2 | 9 | 18 | |
| 145 | NUBP1 levels | PROLV001450 | 13.00 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 146 | Professional qualification | SOCIO000003 | 12.99 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 147 | Orbital disorder | OPHTH000021 | 12.98 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 148 | Syncope | NEURO000025 | 12.95 | Neurologic | B / plasma cell | 0 | 1 | 6 | 10 | |
| 149 | LRRC37A2 levels | PROLV001233 | 12.91 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 150 | WASL levels | PROLV002187 | 12.90 | Protein levels | B / plasma cell | 54 | 2 | 8 | 16 | |
| 151 | IPCEF1/TBCC ratio | PRORT001365 | 12.78 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 152 | CHIT1 levels | PROLV000429 | 12.71 | Protein levels | Myeloid | 45 | 3 | 9 | 16 | |
| 153 | LILRB2 levels | PROLV001214 | 12.50 | Protein levels | Myeloid | 128 | 4 | 13 | 17 | |
| 154 | CD84/TREML2 ratio | PRORT000529 | 12.37 | Protein ratios | B / plasma cell | 3 | 2 | 4 | 10 | |
| 155 | CD79B levels | PROLV000356 | 12.36 | Protein levels | B / plasma cell | 22 | 1 | 6 | 5 | |
| 156 | CHI3L1/PRSS8 ratio | PRORT000611 | 12.33 | Protein ratios | Myeloid | 7 | 5 | 11 | 23 | |
| 157 | Hypercalcaemia | METBL000005 | 12.33 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 158 | Sjogren syndrome | IMMUN000043 | 12.24 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 159 | C1QTNF1/COL18A1 ratio | PRORT000262 | 12.06 | Protein ratios | B / plasma cell | 6 | 3 | 8 | 18 | |
| 160 | ADGRE2 levels | PROLV000043 | 11.96 | Protein levels | Myeloid | 136 | 3 | 10 | 22 | |
| 161 | LTA levels | PROLV001239 | 11.92 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 162 | EFNA4/VWC2 ratio | PRORT000993 | 11.91 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 18 | |
| 163 | CRTAM/ICAM3 ratio | PRORT000770 | 11.82 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 164 | CFHR2 levels | PROLV000415 | 11.78 | Protein levels | Myeloid | 27 | 4 | 9 | 12 | |
| 165 | PDCD1/TNFRSF9 ratio | PRORT001631 | 11.74 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 166 | Drug hypersensitivity | IMMUN000006 | 11.66 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 167 | Medication, hypnotic or sedative | PSYCH000020 | 11.60 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 168 | CD5/TNFRSF9 ratio | PRORT000468 | 11.57 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 169 | NFATC3 levels | PROLV001396 | 11.56 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 170 | Medication, thyroid | ENDOC000002 | 11.56 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 171 | HNRNPK/USP8 ratio | PRORT001293 | 11.55 | Protein ratios | B / plasma cell | 0 | 2 | 9 | 18 | |
| 172 | TYRP1 levels | PROLV002130 | 11.45 | Protein levels | Myeloid | 94 | 5 | 11 | 17 | |
| 173 | Sleep duration | PSYCH000040 | 11.45 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 174 | MGAT2 levels | PROLV001308 | 11.43 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 175 | SORT1/ST6GAL1 ratio | PRORT001803 | 11.42 | Protein ratios | B / plasma cell | 24 | 5 | 11 | 22 | |
| 176 | Neurofibromatosis | NEURO000024 | 11.35 | Neurologic | Lymphocyte | 0 | 3 | 13 | 23 | |
| 177 | CD160/NCR1 ratio | PRORT000378 | 11.31 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 178 | Influenza | IMMUN000065 | 11.30 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 179 | Multiple sclerosis | IMMUN000034 | 11.29 | Immunologic | Lymphocyte | 56 | 2 | 16 | 23 | |
| 180 | Medication, alcohol use disorder | PSYCH000018 | 11.28 | Psychiatric | B / plasma cell | 0 | 5 | 12 | 15 | |
| 181 | ZP3 levels | PROLV002215 | 11.06 | Protein levels | B / plasma cell | 28 | 1 | 6 | 17 | |
| 182 | MAP3K5/MAVS ratio | PRORT001488 | 11.04 | Protein ratios | B / plasma cell | 7 | 3 | 12 | 15 | |
| 183 | RCC1 levels | PROLV001715 | 11.00 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 184 | DAB2/FKBP1B ratio | PRORT000836 | 10.99 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 185 | CCL5/SELP ratio | PRORT000358 | 10.98 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 186 | PECAM1/SOD2 ratio | PRORT001662 | 10.98 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 187 | PADI2 levels | PROLV001483 | 10.89 | Protein levels | B / plasma cell | 4 | 1 | 3 | 8 | |
| 188 | CLEC4G levels | PROLV000453 | 10.75 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 189 | TNFRSF8/TNFRSF9 ratio | PRORT001855 | 10.55 | Protein ratios | Myeloid | 3 | 4 | 12 | 23 | |
| 190 | Rheumatoid arthritis, RA | IMMUN000019 | 10.55 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 191 | Maximal oxygen uptake | CARDI000026 | 10.54 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 192 | LSP1 levels | PROLV001238 | 10.47 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 193 | AIDA levels | PROLV000067 | 10.44 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 194 | GZMA/LTA ratio | PRORT001260 | 10.41 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 195 | C1R levels | PROLV000227 | 10.37 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 196 | PIKFYVE levels | PROLV001559 | 10.36 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 197 | Medication, immunosuppressive | IMMUN000084 | 10.31 | Immunologic | B / plasma cell | 59 | 3 | 8 | 13 | |
| 198 | Fracture fixation | MSKEL000047 | 10.27 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 199 | PRTG levels | PROLV001650 | 10.20 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 200 | SKAP1 levels | PROLV001872 | 10.19 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 201 | SLAMF7 levels | PROLV001876 | 10.16 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 202 | LYN/TACC3 ratio | PRORT001473 | 10.11 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 203 | POMC levels | PROLV001599 | 10.07 | Protein levels | B / plasma cell | 28 | 1 | 3 | 12 | |
| 204 | MMP1/SERPINB6 ratio | PRORT001542 | 10.03 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 9 | 19 | |
| 205 | Supplement use, mineral or vitamin, none | DTSUP000027 | 10.02 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 206 | Immune cell marker, pDC | HEMAT000028 | 9.98 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 207 | TOP1 levels | PROLV002087 | 9.97 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 208 | CD27/NECTIN4 ratio | PRORT000416 | 9.97 | Protein ratios | Lymphocyte | 15 | 2 | 13 | 34 | |
| 209 | TCN2 levels | PROLV002004 | 9.95 | Protein levels | Myeloid | 63 | 2 | 8 | 12 | |
| 210 | CRTAM levels | PROLV000530 | 9.91 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 211 | LGALS8/SOD2 ratio | PRORT001453 | 9.91 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 212 | GABBR2 levels | PROLV000845 | 9.77 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 213 | SERPINA9 levels | PROLV001822 | 9.76 | Protein levels | Hepatocyte | 48 | 3 | 11 | 19 | |
| 214 | ENPP5 levels | PROLV000709 | 9.71 | Protein levels | Myeloid | 71 | 4 | 11 | 13 | |
| 215 | GFRA2 levels | PROLV000877 | 9.70 | Protein levels | Myeloid | 66 | 3 | 18 | 20 | |
| 216 | IL16 levels | PROLV001050 | 9.69 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 217 | Stressful life events | PSYCH000053 | 9.66 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 218 | KDM3A levels | PROLV001132 | 9.65 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 219 | Chalazion | OPHTH000017 | 9.65 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 220 | ARHGAP30 levels | PROLV000137 | 9.61 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 221 | CABP2 levels | PROLV000249 | 9.61 | Protein levels | B / plasma cell | 21 | 2 | 4 | 10 | |
| 222 | Cough | RESPI000027 | 9.59 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 223 | CD22/CD79B ratio | PRORT000399 | 9.59 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 224 | Mental disorder | PSYCH000013 | 9.53 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 225 | CAPN3 levels | PROLV000263 | 9.53 | Protein levels | B / plasma cell | 0 | 2 | 9 | 11 | |
| 226 | MAPRE3 levels | PROLV001273 | 9.51 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 227 | IL2RB levels | PROLV001070 | 9.44 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 228 | IL12A or IL12B levels | PROLV001044 | 9.40 | Protein levels | Myeloid | 210 | 4 | 10 | 21 | |
| 229 | CLEC4C levels | PROLV000451 | 9.39 | Protein levels | Myeloid | 124 | 4 | 9 | 15 | |
| 230 | S100P levels | PROLV001773 | 9.39 | Protein levels | Myeloid | 20 | 4 | 10 | 14 | |
| 231 | REG3A levels | PROLV001719 | 9.37 | Protein levels | B / plasma cell | 29 | 1 | 8 | 10 | |
| 232 | PPP1R2/TACC3 ratio | PRORT001705 | 9.36 | Protein ratios | Lymphocyte | 3 | 3 | 10 | 25 | |
| 233 | EZR levels | PROLV000739 | 9.35 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 234 | TACC3/TBC1D23 ratio | PRORT001824 | 9.29 | Protein ratios | Lymphocyte | 2 | 2 | 9 | 18 | |
| 235 | THBS2 levels | PROLV002026 | 9.29 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 236 | Spleen volume | HEMAT000042 | 9.29 | Hematologic | B / plasma cell | 17 | 4 | 8 | 13 | |
| 237 | CXCL5/PLXNA4 ratio | PRORT000829 | 9.27 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 238 | Medication, antispasmodic | GASTR000015 | 9.21 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 239 | EFNA4/TNFRSF9 ratio | PRORT000992 | 9.20 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 240 | MMP8/OLR1 ratio | PRORT001543 | 9.19 | Protein ratios | Myeloid | 9 | 3 | 10 | 21 | |
| 241 | Pulmonary fibrosis | RESPI000017 | 9.18 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 242 | PDCD6IP levels | PROLV001519 | 9.11 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 243 | ATOX1/TMSB10 ratio | PRORT000153 | 9.04 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 244 | SIT1 levels | PROLV001871 | 9.03 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 245 | CDHR1 levels | PROLV000378 | 8.95 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 24 | |
| 246 | CD244/CRTAM ratio | PRORT000406 | 8.94 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 247 | CD58/MEGF10 ratio | PRORT000477 | 8.89 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 248 | PLXNB2/SEMA7A ratio | PRORT001690 | 8.87 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 249 | RTBDN levels | PROLV001760 | 8.86 | Protein levels | B / plasma cell | 12 | 1 | 6 | 12 | |
| 250 | MCTS1 levels | PROLV001287 | 8.84 | Protein levels | Myeloid | 59 | 3 | 10 | 14 | |
| 251 | ERBB4/F3 ratio | PRORT001046 | 8.83 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 252 | ROR1/TNFRSF21 ratio | PRORT001748 | 8.82 | Protein ratios | Lymphocyte | 8 | 5 | 11 | 19 | |
| 253 | SNX2 levels | PROLV001913 | 8.80 | Protein levels | B / plasma cell | 8 | 1 | 6 | 17 | |
| 254 | CEP85/ZBTB16 ratio | PRORT000604 | 8.78 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 255 | DCTN6/TDRKH ratio | PRORT000875 | 8.77 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 256 | CNTNAP2 levels | PROLV000480 | 8.74 | Protein levels | Myeloid | 28 | 2 | 10 | 16 | |
| 257 | CRTAM/TNFRSF9 ratio | PRORT000774 | 8.65 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 258 | ARTN levels | PROLV000148 | 8.64 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 259 | ANPEP/CXADR ratio | PRORT000100 | 8.57 | Protein ratios | Vascular | 11 | 3 | 12 | 10 | |
| 260 | CA3/HMBS ratio | PRORT000280 | 8.54 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 261 | ITGAL levels | PROLV001108 | 8.50 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 262 | Hereditary haemolytic anaemia | HEMAT000010 | 8.47 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 263 | PFKFB2/SRP14 ratio | PRORT001663 | 8.45 | Protein ratios | Hepatocyte | 10 | 5 | 10 | 28 | |
| 264 | CD48 levels | PROLV000343 | 8.37 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 265 | CD48/CRTAM ratio | PRORT000463 | 8.37 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 266 | TNFRSF6B levels | PROLV002072 | 8.36 | Protein levels | B / plasma cell | 32 | 2 | 8 | 11 | |
| 267 | Phosphatidylserines | LIPID000062 | 8.32 | Lipids | B / plasma cell | 0 | 0 | 5 | 17 | |
| 268 | Thyroid peroxidase antibodies | IMMUN000045 | 8.28 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 269 | CD244/TREML2 ratio | PRORT000410 | 8.25 | Protein ratios | Myeloid | 33 | 5 | 16 | 23 | |
| 270 | Supplement use, dietary | DTSUP000024 | 8.25 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 271 | CD40/TNFRSF14 ratio | PRORT000447 | 8.22 | Protein ratios | Platelet | 8 | 2 | 9 | 14 | |
| 272 | Hypothyroidism, autoimmune | IMMUN000015 | 8.21 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 273 | FCRL3 levels | PROLV000785 | 8.20 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 274 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 8.19 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 275 | TDRKH/TST ratio | PRORT001830 | 8.18 | Protein ratios | Myeloid | 11 | 6 | 16 | 28 | |
| 276 | Retirement wellbeing | SOCIO000027 | 8.11 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 277 | Educational attainment | SOCIO000002 | 8.09 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 278 | Eosinophil | HEMAT000030 | 8.08 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 279 | LGALS4 levels | PROLV001204 | 8.07 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 280 | Handedness | BEHAV000003 | 8.04 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 281 | F9/FURIN ratio | PRORT001091 | 7.97 | Protein ratios | Myeloid | 3 | 2 | 10 | 13 | |
| 282 | LTA/LTBR ratio | PRORT001463 | 7.97 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 283 | PFKM levels | PROLV001541 | 7.89 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 284 | TNFRSF4/TNFRSF8 ratio | PRORT001853 | 7.88 | Protein ratios | Vascular | 2 | 2 | 6 | 10 | |
| 285 | ITGB7 levels | PROLV001116 | 7.87 | Protein levels | Hepatocyte | 157 | 4 | 17 | 37 | |
| 286 | Polyglandular dysfunction | IMMUN000037 | 7.85 | Immunologic | B / plasma cell | 0 | 3 | 10 | 21 | |
| 287 | Wisdom tooth surgery | DENTA000005 | 7.84 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 288 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 7.80 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 289 | AFP levels | PROLV000053 | 7.78 | Protein levels | Hepatocyte | 177 | 1 | 5 | 7 | |
| 290 | CD163 levels | PROLV000312 | 7.78 | Protein levels | Myeloid | 134 | 4 | 13 | 17 | |
| 291 | CCL3 levels | PROLV000296 | 7.77 | Protein levels | Myeloid | 77 | 3 | 9 | 19 | |
| 292 | Latent factor, white cell | HEMAT000039 | 7.76 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 293 | SEMA4C levels | PROLV001809 | 7.74 | Protein levels | Hepatocyte | 20 | 4 | 17 | 38 | |
| 294 | TNFRSF11A levels | PROLV002060 | 7.74 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 295 | ADM levels | PROLV000051 | 7.72 | Protein levels | B / plasma cell | 52 | 1 | 6 | 13 | |
| 296 | NOTCH1/SEMA7A ratio | PRORT001591 | 7.70 | Protein ratios | B / plasma cell | 20 | 2 | 11 | 15 | |
| 297 | Cervicobrachial syndrome | MSKEL000073 | 7.63 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 298 | TSC1 levels | PROLV002112 | 7.61 | Protein levels | Hepatocyte | 18 | 5 | 23 | 29 | |
| 299 | RAP1A levels | PROLV001704 | 7.59 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 300 | BMP7 levels | PROLV000205 | 7.59 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 301 | DRAXIN levels | PROLV000651 | 7.41 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 302 | ICAM3/LY9 ratio | PRORT001326 | 7.41 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 303 | QPCT levels | PROLV001693 | 7.38 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 304 | CCDC50 levels | PROLV000275 | 7.36 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 305 | GZMB levels | PROLV000948 | 7.33 | Protein levels | Lymphocyte | 108 | 3 | 14 | 28 | |
| 306 | CASP8/PPP3R1 ratio | PRORT000322 | 7.32 | Protein ratios | Lymphocyte | 5 | 1 | 8 | 25 | |
| 307 | Urticaria | IMMUN000007 | 7.31 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 308 | Degenerative skin disorder | DERMA000038 | 7.30 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 309 | PDZK1 levels | PROLV001531 | 7.29 | Protein levels | Hepatocyte | 27 | 3 | 12 | 25 | |
| 310 | Meat preference | DTSUP000015 | 7.28 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 311 | CD209/CLEC14A ratio | PRORT000395 | 7.25 | Protein ratios | B / plasma cell | 0 | 2 | 5 | 7 | |
| 312 | Skin and soft tissue infection | IMMUN000073 | 7.23 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 313 | Hypothyroidism | ENDOC000021 | 7.23 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 314 | CTSO levels | PROLV000567 | 7.21 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 315 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 7.21 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 316 | CD164/CD99 ratio | PRORT000386 | 7.19 | Protein ratios | Myeloid | 8 | 4 | 7 | 14 | |
| 317 | CD6 levels | PROLV000349 | 7.19 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 318 | Drug poisoning | MISCL000036 | 7.17 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 319 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 7.16 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 320 | Loneliness | PSYCH000055 | 7.15 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 321 | Medication, insulin therapy | METBL000027 | 7.13 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 322 | APBB1IP/POLR2F ratio | PRORT000115 | 7.12 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 323 | CD163/MARCO ratio | PRORT000383 | 7.12 | Protein ratios | Myeloid | 64 | 4 | 11 | 20 | |
| 324 | CD101 levels | PROLV000308 | 7.12 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 325 | Heme malignancy, Lymphoma | MALIG000044 | 7.12 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 326 | LCN2/PRTN3 ratio | PRORT001442 | 7.11 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 327 | ST13 levels | PROLV001951 | 7.09 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 328 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 7.05 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 329 | Allergic conjunctivitis | IMMUN000002 | 7.04 | Immunologic | Lymphocyte | 34 | 2 | 8 | 28 | |
| 330 | SNX15 levels | PROLV001911 | 7.02 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 331 | Benign neoplasm, Endocrine | MALIG000003 | 7.02 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 332 | Myasthenia gravis | IMMUN000035 | 6.98 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 333 | NME3 levels | PROLV001409 | 6.98 | Protein levels | Myeloid | 92 | 4 | 15 | 35 | |
| 334 | ADD1 levels | PROLV000039 | 6.97 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 335 | SDK2 levels | PROLV001800 | 6.96 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 336 | MMP1 levels | PROLV001321 | 6.93 | Protein levels | Hematopoietic progenitor | 57 | 6 | 11 | 19 | |
| 337 | Physical activity | BEHAV000007 | 6.90 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 338 | Corrective lens use | OPHTH000032 | 6.86 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 339 | Gut microbial pathway abundance | GASTR000038 | 6.86 | Gastrointestinal | Hepatocyte | 0 | 3 | 9 | 26 | |
| 340 | HDAC8 levels | PROLV000958 | 6.84 | Protein levels | B / plasma cell | — | 1 | 12 | 24 | |
| 341 | PPP1R2/USP8 ratio | PRORT001708 | 6.83 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 342 | Schizophrenia | PSYCH000036 | 6.82 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 343 | Household composition | SOCIO000010 | 6.80 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 344 | Cereal preference | DTSUP000010 | 6.79 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 345 | GALNT5 levels | PROLV000851 | 6.78 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 346 | Autoimmune disease | IMMUN000023 | 6.78 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 347 | ADGRE5/VCAM1 ratio | PRORT000034 | 6.76 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 348 | Nephrotic syndrome | NEPHR000011 | 6.75 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 349 | MAMDC4 levels | PROLV001259 | 6.75 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 350 | CD48/SLAMF7 ratio | PRORT000465 | 6.75 | Protein ratios | Lymphocyte | 35 | 4 | 17 | 42 | |
| 351 | Vehicle ownership | SOCIO000015 | 6.72 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 352 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 6.68 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 353 | LAYN/VWC2 ratio | PRORT001436 | 6.68 | Protein ratios | Hepatocyte | 3 | 3 | 10 | 17 | |
| 354 | Atrioventricular block | CARDI000028 | 6.68 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 355 | ITGB1/ITGB2 ratio | PRORT001376 | 6.67 | Protein ratios | Myeloid | 75 | 3 | 15 | 21 | |
| 356 | Immune cell marker, B cell | HEMAT000021 | 6.66 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 357 | ARNT levels | PROLV000144 | 6.61 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 358 | LCN2/PGLYRP1 ratio | PRORT001441 | 6.61 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 359 | ADGRE5/SEMA7A ratio | PRORT000033 | 6.60 | Protein ratios | Myeloid | 18 | 2 | 6 | 13 | |
| 360 | CCL17/PDGFB ratio | PRORT000346 | 6.58 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 361 | S100A14 levels | PROLV001769 | 6.55 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 362 | CD160 levels | PROLV000311 | 6.54 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 363 | FUT8/TNFSF14 ratio | PRORT001192 | 6.53 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 364 | Stressful life events, none | PSYCH000050 | 6.52 | Psychiatric | Neural / glial | 7 | 6 | 15 | 10 | |
| 365 | GALNT10/SEMA7A ratio | PRORT001202 | 6.52 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 366 | Reimbursement for rheumatic disease | IMMUN000042 | 6.52 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 367 | ICAM3 levels | PROLV001006 | 6.50 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 368 | LAIR1 levels | PROLV001176 | 6.50 | Protein levels | Myeloid | 23 | 4 | 9 | 17 | |
| 369 | ADGRE1 levels | PROLV000042 | 6.45 | Protein levels | Myeloid | 90 | 4 | 8 | 17 | |
| 370 | Cancer, Testis | MALIG000031 | 6.43 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 371 | LGALS4/PCDH17 ratio | PRORT001450 | 6.42 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 10 | |
| 372 | B2M levels | PROLV000169 | 6.38 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 373 | CALCOCO1/CRACR2A ratio | PRORT000293 | 6.37 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 374 | STC1 levels | PROLV001960 | 6.35 | Protein levels | Vascular | 2 | 1 | 6 | 12 | |
| 375 | CD163/ICAM1 ratio | PRORT000381 | 6.34 | Protein ratios | Myeloid | 21 | 5 | 19 | 38 | |
| 376 | BLMH/PEAR1 ratio | PRORT000236 | 6.33 | Protein ratios | Hepatocyte | 17 | 3 | 13 | 15 | |
| 377 | Estradiol | ENDOC000006 | 6.33 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 378 | CEP43/MPHOSPH8 ratio | PRORT000599 | 6.32 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 379 | Impacted cerumen | AUDIO000002 | 6.32 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 380 | CLEC4G/MERTK ratio | PRORT000661 | 6.31 | Protein ratios | Myeloid | 78 | 5 | 18 | 29 | |
| 381 | MDGA1 levels | PROLV001288 | 6.30 | Protein levels | Hepatocyte | 14 | 2 | 9 | 10 | |
| 382 | IFI30 levels | PROLV001014 | 6.30 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 383 | PGLYRP1 levels | PROLV001546 | 6.28 | Protein levels | Myeloid | 82 | 4 | 8 | 9 | |
| 384 | SUSD2 levels | PROLV001979 | 6.28 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 385 | CRTAM/VCAM1 ratio | PRORT000775 | 6.26 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 386 | Sun exposure | BEHAV000001 | 6.23 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 387 | Osteochondrodysplasia | MSKEL000054 | 6.22 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 388 | Family history, skin cancer | MALIG000040 | 6.18 | Malignancy | B / plasma cell | 8 | 0 | 3 | 9 | |
| 389 | FAM151A levels | PROLV000760 | 6.16 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 390 | Pregnancy complication, abortive | REPRO000027 | 6.14 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 391 | L1CAM levels | PROLV001171 | 6.13 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 392 | ADM/CLMP ratio | PRORT000045 | 6.12 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 393 | CEP43/USP8 ratio | PRORT000602 | 6.12 | Protein ratios | Myeloid | 0 | 2 | 8 | 27 | |
| 394 | CRTAM/PDCD1 ratio | PRORT000773 | 6.11 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 395 | IL7R levels | PROLV001081 | 6.11 | Protein levels | Hepatocyte | 78 | 3 | 10 | 27 | |
| 396 | PADI4 levels | PROLV001484 | 6.10 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 397 | SEMA7A levels | PROLV001811 | 6.10 | Protein levels | Myeloid | 113 | 2 | 11 | 23 | |
| 398 | S100A11/SERPINB8 ratio | PRORT001754 | 6.08 | Protein ratios | Myeloid | 17 | 3 | 8 | 13 | |
| 399 | CRISP2 levels | PROLV000524 | 6.08 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 400 | BAG6/BMP6 ratio | PRORT000200 | 6.07 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 38 | |
| 401 | EIF3J levels | PROLV000694 | 6.04 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 402 | TNFRSF9 levels | PROLV002074 | 6.04 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 403 | CA1/HMBS ratio | PRORT000269 | 6.01 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 404 | FAM3B/GPA33 ratio | PRORT001113 | 5.99 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 405 | Medical conditions, allergy etc, none | MISCL000026 | 5.95 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 406 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 5.93 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 407 | Gut microbial abundance, Rubneribacter | GASTR000035 | 5.92 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 408 | KLRB1 levels | PROLV001161 | 5.90 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 409 | FLT3 levels | PROLV000816 | 5.88 | Protein levels | Myeloid | 50 | 4 | 11 | 22 | |
| 410 | NPTXR levels | PROLV001428 | 5.88 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 411 | CD200/CLEC4G ratio | PRORT000392 | 5.86 | Protein ratios | Granulosa cell | 34 | 3 | 10 | 20 | |
| 412 | CTSC levels | PROLV000561 | 5.84 | Protein levels | Hepatocyte | 71 | 3 | 13 | 17 | |
| 413 | Pain, neck | MSKEL000040 | 5.83 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 414 | CHRDL1 levels | PROLV000433 | 5.83 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 415 | C1QL2 levels | PROLV000223 | 5.82 | Protein levels | Vascular | 43 | 2 | 7 | 24 | |
| 416 | IL22 levels | PROLV001066 | 5.79 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 417 | FABP1/SULT2A1 ratio | PRORT001097 | 5.79 | Protein ratios | Hepatocyte | 10 | 4 | 8 | 18 | |
| 418 | Digestive system disorder | GASTR000006 | 5.78 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 419 | ATP5IF1/FXN ratio | PRORT000157 | 5.78 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 420 | LAIR2 levels | PROLV001177 | 5.77 | Protein levels | Lymphocyte | 49 | 2 | 12 | 22 | |
| 421 | Polyarthropathy | MSKEL000019 | 5.75 | Musculoskeletal | Lymphocyte | 65 | 2 | 13 | 23 | |
| 422 | GHRL levels | PROLV000886 | 5.74 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 423 | CRTAM/GZMA ratio | PRORT000769 | 5.74 | Protein ratios | Lymphocyte | 34 | 3 | 14 | 33 | |
| 424 | COLEC12/TAFA5 ratio | PRORT000706 | 5.74 | Protein ratios | B / plasma cell | 13 | 1 | 6 | 11 | |
| 425 | Sexual behaviour | BEHAV000012 | 5.73 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 426 | CCN2/VEGFC ratio | PRORT000371 | 5.69 | Protein ratios | Hematopoietic progenitor | 24 | 4 | 9 | 19 | |
| 427 | CC2D1A/CRADD ratio | PRORT000327 | 5.68 | Protein ratios | Myeloid | 1 | 3 | 7 | 21 | |
| 428 | Grain and bakery preference | DTSUP000013 | 5.68 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 429 | AZU1/CEACAM8 ratio | PRORT000184 | 5.66 | Protein ratios | Myeloid | 24 | 2 | 5 | 14 | |
| 430 | VAMP5 levels | PROLV002148 | 5.65 | Protein levels | Hepatocyte | 9 | 3 | 10 | 18 | |
| 431 | Graves disease | IMMUN000027 | 5.62 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 432 | CDKN1A/TXLNA ratio | PRORT000575 | 5.61 | Protein ratios | Myeloid | 15 | 4 | 12 | 14 | |
| 433 | IGDCC4 levels | PROLV001024 | 5.61 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 434 | ADH4/KYNU ratio | PRORT000041 | 5.60 | Protein ratios | Hepatocyte | 41 | 4 | 16 | 28 | |
| 435 | IBD-Inflammatory bowel disease | IMMUN000030 | 5.57 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 436 | CD28 levels | PROLV000327 | 5.56 | Protein levels | B / plasma cell | 26 | 1 | 10 | 17 | |
| 437 | MNDA levels | PROLV001329 | 5.56 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 438 | CD244 levels | PROLV000322 | 5.56 | Protein levels | Muscle / cardiac | 28 | 4 | 19 | 38 | |
| 439 | CXCL11 levels | PROLV000577 | 5.54 | Protein levels | Myeloid | 47 | 4 | 9 | 18 | |
| 440 | Cancer, Urinary tract | MALIG000033 | 5.54 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 441 | LGALS3BP levels | PROLV001203 | 5.52 | Protein levels | Myeloid | 120 | 3 | 12 | 16 | |
| 442 | Supplement use, mineral or vitamin | DTSUP000026 | 5.52 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 443 | Household income | SOCIO000026 | 5.51 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 444 | NFASC levels | PROLV001394 | 5.50 | Protein levels | Hepatocyte | 57 | 3 | 12 | 27 | |
| 445 | UCMA levels | PROLV002135 | 5.49 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 446 | SLC4A1 levels | PROLV001882 | 5.41 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 447 | FOXO1/USP8 ratio | PRORT001177 | 5.41 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 448 | CTSZ/HSPG2 ratio | PRORT000804 | 5.38 | Protein ratios | Hepatocyte | 35 | 5 | 12 | 20 | |
| 449 | CLEC4G/NELL2 ratio | PRORT000662 | 5.37 | Protein ratios | Myeloid | 35 | 5 | 16 | 39 | |
| 450 | Flavour preference | DTSUP000022 | 5.36 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 451 | Allergic disease | IMMUN000003 | 5.36 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 452 | TNF/TNFRSF1B ratio | PRORT001844 | 5.35 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 453 | COL9A1 levels | PROLV000493 | 5.35 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 454 | CD93/CLEC14A ratio | PRORT000531 | 5.35 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 455 | CXCL5/SERPINE1 ratio | PRORT000832 | 5.34 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 456 | Sedentary behaviour | BEHAV000008 | 5.34 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 457 | Lichen disorder | DERMA000013 | 5.33 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 458 | FOXO1/MAP4K5 ratio | PRORT001173 | 5.33 | Protein ratios | Lymphocyte | 0 | 3 | 12 | 41 | |
| 459 | IL12RB1 levels | PROLV001046 | 5.32 | Protein levels | Muscle / cardiac | 54 | 5 | 14 | 18 | |
| 460 | Thyroid disorder | ENDOC000023 | 5.32 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 461 | FKBP7 levels | PROLV000811 | 5.31 | Protein levels | Myeloid | 1 | 4 | 12 | 28 | |
| 462 | MED18/TACC3 ratio | PRORT001510 | 5.30 | Protein ratios | Lymphocyte | 0 | 4 | 8 | 24 | |
| 463 | ARHGAP25/RNF41 ratio | PRORT000139 | 5.30 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 464 | SUOX levels | PROLV001977 | 5.29 | Protein levels | Hepatocyte | 27 | 1 | 13 | 31 | |
| 465 | Rotator cuff disorder | MSKEL000066 | 5.29 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 466 | TIMD4 levels | PROLV002035 | 5.28 | Protein levels | Myeloid | 181 | 2 | 9 | 21 | |
| 467 | ALCAM/LRRC25 ratio | PRORT000073 | 5.27 | Protein ratios | Myeloid | 48 | 3 | 9 | 17 | |
| 468 | ITGB1BP2/USP8 ratio | PRORT001390 | 5.26 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 469 | RNASET2 levels | PROLV001742 | 5.26 | Protein levels | Myeloid | 94 | 2 | 9 | 15 | |
| 470 | C1QA levels | PROLV000222 | 5.26 | Protein levels | Myeloid | 186 | 2 | 8 | 10 | |
| 471 | Retinal vascular disorder | OPHTH000044 | 5.24 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 472 | CCNE1 levels | PROLV000306 | 5.22 | Protein levels | B / plasma cell | 8 | 0 | 6 | 17 | |
| 473 | Joint disorder | MSKEL000015 | 5.21 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 474 | LCN2/RETN ratio | PRORT001443 | 5.20 | Protein ratios | Myeloid | 41 | 2 | 8 | 14 | |
| 475 | GYS1/PPP1R2 ratio | PRORT001255 | 5.18 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 476 | BLVRB/CA1 ratio | PRORT000238 | 5.17 | Protein ratios | Myeloid | 1 | 2 | 5 | 11 | |
| 477 | MPHOSPH8/USP8 ratio | PRORT001555 | 5.17 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 478 | Psoriasis | IMMUN000039 | 5.16 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 479 | CASP8/DDX58 ratio | PRORT000321 | 5.14 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 480 | ITGB2 levels | PROLV001113 | 5.14 | Protein levels | Myeloid | 155 | 2 | 18 | 27 | |
| 481 | MAP3K5/ZBTB16 ratio | PRORT001489 | 5.13 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 482 | Occupational physical activity | BEHAV000006 | 5.12 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 483 | SH2D1A levels | PROLV001852 | 5.10 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 484 | GOLM2/ITGA5 ratio | PRORT001222 | 5.10 | Protein ratios | Myeloid | 32 | 5 | 14 | 32 | |
| 485 | BSG/LY9 ratio | PRORT000249 | 5.10 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 486 | Memory function | PSYCH000007 | 5.09 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 487 | Body fat percentage, sex interaction | BCOMP000002 | 5.08 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 488 | ICAM3/SLAMF7 ratio | PRORT001328 | 5.07 | Protein ratios | Myeloid | 27 | 3 | 19 | 22 | |
| 489 | FCRL5/MZB1 ratio | PRORT001135 | 5.07 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 490 | Social activity, none | SOCIO000018 | 5.04 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 491 | CALCOCO1/TJAP1 ratio | PRORT000303 | 5.03 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 492 | Erythematosquamous dermatosis | DERMA000009 | 5.02 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 493 | PDCD1 levels | PROLV001515 | 5.01 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 494 | ADAM12 levels | PROLV000025 | 5.00 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 495 | Age at onset of walking | NEURO000023 | 4.99 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 496 | Pregnancy termination | BEHAV000010 | 4.96 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 497 | CXCL17/LAMP3 ratio | PRORT000823 | 4.96 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 498 | Frailty, unhealthy lifestyle | BEHAV000002 | 4.93 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 499 | YOD1 levels | PROLV002206 | 4.93 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 500 | BCR/ITGB1BP2 ratio | PRORT000227 | 4.92 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 501 | CD160/CXCL16 ratio | PRORT000376 | 4.92 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 502 | GZMH/KLRD1 ratio | PRORT001264 | 4.92 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 503 | PRAP1 levels | PROLV001623 | 4.91 | Protein levels | Hematopoietic progenitor | 16 | 2 | 6 | 11 | |
| 504 | Medication, anti-asthmatic | IMMUN000082 | 4.91 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 505 | Sugar alcohols | METAB000037 | 4.91 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 506 | Mood symptoms | PSYCH000029 | 4.91 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 507 | LBP levels | PROLV001188 | 4.90 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 508 | MMP13 levels | PROLV001324 | 4.90 | Protein levels | Stromal / connective | 0 | 1 | 4 | 5 | |
| 509 | Immunoglobulin deficiency | IMMUN000049 | 4.89 | Immunologic | B / plasma cell | 4 | 2 | 3 | 11 | |
| 510 | MCAM/NCAM1 ratio | PRORT001505 | 4.88 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 511 | MANSC1/PODXL2 ratio | PRORT001484 | 4.87 | Protein ratios | Hepatocyte | 3 | 2 | 10 | 22 | |
| 512 | Social relationships | SOCIO000021 | 4.87 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 513 | CILP levels | PROLV000436 | 4.86 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 514 | Enthesopathy | MSKEL000061 | 4.85 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 515 | KEL levels | PROLV001134 | 4.85 | Protein levels | Hepatocyte | 60 | 3 | 15 | 28 | |
| 516 | Thyrotoxicosis | ENDOC000024 | 4.84 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 517 | ADH4/CA5A ratio | PRORT000038 | 4.84 | Protein ratios | Hepatocyte | 30 | 2 | 14 | 26 | |
| 518 | FASLG levels | PROLV000771 | 4.83 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 519 | FABP1 levels | PROLV000751 | 4.82 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 520 | Frailty, metabolic problems | METBL000011 | 4.82 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 521 | LYVE1 levels | PROLV001254 | 4.82 | Protein levels | Myeloid | 54 | 2 | 8 | 10 | |
| 522 | Psoriatic arthritis vs psoriasis | IMMUN000041 | 4.81 | Immunologic | Neural / glial | 7 | 3 | 10 | 12 | |
| 523 | IL12B levels | PROLV001045 | 4.81 | Protein levels | Myeloid | 205 | 3 | 7 | 10 | |
| 524 | FCAMR levels | PROLV000774 | 4.80 | Protein levels | Hepatocyte | 81 | 2 | 8 | 20 | |
| 525 | LYZL2 levels | PROLV001255 | 4.79 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 526 | Skin sebum | DERMA000036 | 4.79 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 527 | Ocular refraction | OPHTH000033 | 4.79 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 528 | FOLR3/KLK8 ratio | PRORT001171 | 4.79 | Protein ratios | Myeloid | 24 | 2 | 10 | 15 | |
| 529 | Mosaic chromosomal alteration | MISCL000014 | 4.77 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 530 | VEGFB levels | PROLV002158 | 4.76 | Protein levels | Lymphocyte | 54 | 3 | 14 | 35 | |
| 531 | SULT2A1 levels | PROLV001974 | 4.76 | Protein levels | Hepatocyte | 51 | 1 | 4 | 21 | |
| 532 | Peripheral nerve disorder | NEURO000031 | 4.76 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 533 | Tonsillar and adenoidal disorders | RESPI000040 | 4.75 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 534 | DCTPP1 levels | PROLV000605 | 4.75 | Protein levels | Myeloid | 47 | 2 | 11 | 16 | |
| 535 | PTPRC levels | PROLV001674 | 4.74 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 536 | Lactase deficiency | METBL000002 | 4.74 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 537 | KYNU/SCLY ratio | PRORT001416 | 4.71 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 538 | Infant mortality rate | MISCL000003 | 4.71 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 539 | CALCOCO1/IRAG2 ratio | PRORT000297 | 4.69 | Protein ratios | Neural / glial | 0 | 2 | 18 | 34 | |
| 540 | SIGLEC1 levels | PROLV001859 | 4.68 | Protein levels | Myeloid | 115 | 3 | 13 | 17 | |
| 541 | Shoulder lesion | MSKEL000068 | 4.68 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 542 | LRIG3 levels | PROLV001228 | 4.67 | Protein levels | Lymphocyte | 0 | 0 | 9 | 20 | |
| 543 | CXCL5/EDAR ratio | PRORT000827 | 4.66 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 544 | FOXO3 levels | PROLV000826 | 4.66 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 545 | PITHD1 levels | PROLV001563 | 4.65 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 546 | ABL1/DNMBP ratio | PRORT000009 | 4.64 | Protein ratios | Hepatocyte | 1 | 1 | 9 | 21 | |
| 547 | EIF4G1/NFATC1 ratio | PRORT001012 | 4.63 | Protein ratios | Myeloid | 0 | 1 | 8 | 14 | |
| 548 | Hyperthyroidism, autoimmune | IMMUN000014 | 4.62 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 549 | SMAD1/ZBTB16 ratio | PRORT001791 | 4.62 | Protein ratios | Muscle / cardiac | 9 | 3 | 9 | 25 | |
| 550 | TGFA levels | PROLV002019 | 4.61 | Protein levels | Myeloid | 15 | 2 | 10 | 15 | |
| 551 | METAP2/PFKFB2 ratio | PRORT001523 | 4.60 | Protein ratios | Muscle / cardiac | 1 | 3 | 9 | 18 | |
| 552 | HHIP levels | PROLV000969 | 4.60 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 553 | SSC4D levels | PROLV001947 | 4.59 | Protein levels | Hepatocyte | 51 | 3 | 8 | 15 | |
| 554 | CXCL5/PPIB ratio | PRORT000830 | 4.59 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 555 | PAM levels | PROLV001492 | 4.58 | Protein levels | Myeloid | 112 | 2 | 11 | 21 | |
| 556 | Iron metabolism disorder | METBL000019 | 4.58 | Metabolic | Myeloid | 59 | 1 | 5 | 24 | |
| 557 | ADH4/RBP5 ratio | PRORT000042 | 4.56 | Protein ratios | Myeloid | 18 | 2 | 10 | 14 | |
| 558 | Pregnancy complication, oedema | REPRO000032 | 4.55 | Reproductive | B / plasma cell | 3 | 0 | 3 | 2 | |
| 559 | Arginine metabolites | METAB000003 | 4.54 | Metabolites | B / plasma cell | 3 | 0 | 1 | 2 | |
| 560 | GSTA4 levels | PROLV000941 | 4.54 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 561 | FXYD5/TMSB10 ratio | PRORT001196 | 4.54 | Protein ratios | Muscle / cardiac | 6 | 3 | 6 | 18 | |
| 562 | CLEC4A levels | PROLV000450 | 4.53 | Protein levels | Myeloid | 121 | 3 | 13 | 20 | |
| 563 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 4.52 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 564 | Neoplasm, Skin | MALIG000034 | 4.52 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 565 | NUDT5/TXNRD1 ratio | PRORT001611 | 4.50 | Protein ratios | Granulosa cell | 19 | 5 | 8 | 9 | |
| 566 | Pain, none | MSKEL000041 | 4.50 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 567 | External ear disorder | AUDIO000001 | 4.48 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 568 | BAP18 levels | PROLV000179 | 4.48 | Protein levels | Vascular | 44 | 4 | 13 | 39 | |
| 569 | Viral wart | IMMUN000079 | 4.47 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 570 | CXCL10 levels | PROLV000576 | 4.46 | Protein levels | Myeloid | 89 | 2 | 9 | 19 | |
| 571 | CSF1/IFNGR1 ratio | PRORT000776 | 4.46 | Protein ratios | Granulosa cell | 1 | 4 | 8 | 13 | |
| 572 | Purine metabolites | METAB000062 | 4.46 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 573 | Dyspnoea | RESPI000028 | 4.46 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 574 | PAFAH1B3 levels | PROLV001486 | 4.45 | Protein levels | Lymphocyte | 45 | 2 | 17 | 18 | |
| 575 | BIN2/FYB1 ratio | PRORT000232 | 4.45 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 576 | NMNAT1 levels | PROLV001411 | 4.45 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 577 | Suicidal behaviour | PSYCH000037 | 4.44 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 578 | Irritable bowel syndrome | GASTR000004 | 4.42 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 579 | Nutritional and metabolic symptoms | METBL000016 | 4.40 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 580 | CSNK1D levels | PROLV000542 | 4.40 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 581 | Hypertriglyceridaemia | METBL000023 | 4.38 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 582 | CWC15 levels | PROLV000572 | 4.38 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 583 | PCDH17/SEMA7A ratio | PRORT001626 | 4.38 | Protein ratios | Granulosa cell | 1 | 4 | 7 | 16 | |
| 584 | POSTN levels | PROLV001603 | 4.38 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 585 | ITM2A levels | PROLV001120 | 4.37 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 586 | Social activity | SOCIO000020 | 4.35 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 587 | COL28A1 levels | PROLV000487 | 4.35 | Protein levels | B / plasma cell | 11 | 0 | 4 | 14 | |
| 588 | GZMA/TNFRSF8 ratio | PRORT001262 | 4.35 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 589 | Operation, respiratory | RESPI000025 | 4.33 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 590 | CD48/FCRL6 ratio | PRORT000464 | 4.32 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 591 | EXTL1 levels | PROLV000738 | 4.31 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 592 | NBN levels | PROLV001376 | 4.31 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 593 | PALM3 levels | PROLV001491 | 4.30 | Protein levels | Myeloid | 37 | 2 | 7 | 12 | |
| 594 | CXCL16/NOTCH1 ratio | PRORT000822 | 4.30 | Protein ratios | Vascular | 15 | 3 | 15 | 44 | |
| 595 | HLAE/IL15 ratio | PRORT001287 | 4.29 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 596 | CASP3/LYN ratio | PRORT000314 | 4.29 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 597 | Disability allowance | SOCIO000019 | 4.28 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 598 | Frailty, general | MISCL000039 | 4.28 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 599 | MMP8/TGFA ratio | PRORT001545 | 4.28 | Protein ratios | Myeloid | 0 | 1 | 8 | 8 | |
| 600 | ARSA/CD164 ratio | PRORT000142 | 4.24 | Protein ratios | Hepatocyte | 37 | 3 | 8 | 25 | |
| 601 | Bleeding | HEMAT000016 | 4.24 | Hematologic | B / plasma cell | 9 | 1 | 4 | 17 | |
| 602 | CD163/MSR1 ratio | PRORT000384 | 4.24 | Protein ratios | Myeloid | 62 | 3 | 10 | 14 | |
| 603 | ACY1/SCLY ratio | PRORT000021 | 4.23 | Protein ratios | Hepatocyte | 6 | 3 | 12 | 17 | |
| 604 | ICAM2/IL7R ratio | PRORT001324 | 4.23 | Protein ratios | Vascular | 6 | 1 | 8 | 17 | |
| 605 | Alcohol consumption | PSYCH000041 | 4.23 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 606 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 4.22 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 607 | ADA levels | PROLV000023 | 4.21 | Protein levels | Myeloid | 17 | 5 | 18 | 32 | |
| 608 | Xenobiotic metabolites | METAB000080 | 4.20 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 609 | Food preparation preference | DTSUP000021 | 4.19 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 610 | Employment status | SOCIO000005 | 4.19 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 611 | BAMBI levels | PROLV000177 | 4.18 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 612 | TIE1 levels | PROLV002033 | 4.18 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 613 | Conjunctivitis | OPHTH000002 | 4.17 | Ophthalmic | Lymphocyte | 26 | 3 | 10 | 30 | |
| 614 | UXS1 levels | PROLV002147 | 4.17 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 615 | INSR levels | PROLV001094 | 4.16 | Protein levels | Lymphocyte | 42 | 1 | 7 | 30 | |
| 616 | Ventricular wall thickness | CARDI000016 | 4.16 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 617 | GBP6 levels | PROLV000863 | 4.15 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 618 | CD58/MCAM ratio | PRORT000476 | 4.14 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 619 | PLAUR levels | PROLV001573 | 4.12 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 620 | AK1 levels | PROLV000070 | 4.12 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 621 | CD6/EZR ratio | PRORT000484 | 4.11 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 622 | CD70 levels | PROLV000353 | 4.11 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 623 | Dissociative disorder | PSYCH000012 | 4.11 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 624 | DKK3 levels | PROLV000621 | 4.11 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 625 | GDNF levels | PROLV000872 | 4.10 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 626 | APBB1IP levels | PROLV000112 | 4.10 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 627 | CD1C/CD207 ratio | PRORT000391 | 4.10 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 628 | NTN1 levels | PROLV001444 | 4.07 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 629 | Skin eruption | DERMA000027 | 4.06 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 630 | MSRA/PRDX5 ratio | PRORT001562 | 4.06 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 631 | REG1B/REG3A ratio | PRORT001732 | 4.06 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 632 | STX6 levels | PROLV001969 | 4.05 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 633 | Dementia | NEURO000019 | 4.05 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 634 | CDSN/LY6D ratio | PRORT000583 | 4.04 | Protein ratios | Cutaneous epithelium | 33 | 2 | 18 | 32 | |
| 635 | MMP8/PGLYRP1 ratio | PRORT001544 | 4.04 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 636 | MAN2B2 levels | PROLV001261 | 4.02 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 637 | GZMB/IL15 ratio | PRORT001263 | 4.02 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 638 | Smoking effects on COPD | RESPI000012 | 4.02 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 639 | CD27/ICAM3 ratio | PRORT000414 | 4.01 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 640 | LAYN/TNFRSF4 ratio | PRORT001434 | 4.01 | Protein ratios | Myeloid | 8 | 3 | 7 | 11 | |
| 641 | CD300A levels | PROLV000329 | 4.00 | Protein levels | Lymphocyte | 39 | 4 | 18 | 41 | |
| 642 | Tyrosine | METAB000031 | 4.00 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 643 | Brain age gap | NIMAG000004 | 3.99 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 644 | Medication, chronic lung disease | RESPI000006 | 3.99 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 645 | PCBD1 levels | PROLV001502 | 3.99 | Protein levels | Hepatocyte | 64 | 4 | 17 | 39 | |
| 646 | Medication, proton pump inhibitor | GASTR000017 | 3.98 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 647 | CEBPB levels | PROLV000395 | 3.98 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 648 | Hospital discharge | MISCL000023 | 3.96 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 649 | Endocrine gland disorder | ENDOC000003 | 3.95 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 650 | AZU1/RNASE3 ratio | PRORT000186 | 3.94 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 651 | NPHS2 levels | PROLV001422 | 3.94 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 652 | Rosacea | DERMA000019 | 3.93 | Dermatologic | Lymphocyte | 37 | 2 | 14 | 19 | |
| 653 | BIN1 levels | PROLV000196 | 3.92 | Protein levels | Muscle / cardiac | 0 | 2 | 10 | 18 | |
| 654 | Hyperthyroidism | ENDOC000020 | 3.90 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 655 | CALCOCO1/PDLIM7 ratio | PRORT000300 | 3.90 | Protein ratios | Myeloid | 1 | 3 | 11 | 27 | |
| 656 | CD4/LILRB4 ratio | PRORT000441 | 3.90 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 657 | Vegetable preference | DTSUP000020 | 3.90 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 658 | L1CAM/SEZ6L ratio | PRORT001417 | 3.89 | Protein ratios | Myeloid | 3 | 1 | 8 | 17 | |
| 659 | Medication, Crohn disease | IMMUN000081 | 3.89 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 660 | SFTPA1 levels | PROLV001847 | 3.89 | Protein levels | B / plasma cell | 0 | 0 | 3 | 9 | |
| 661 | TFF3 levels | PROLV002014 | 3.88 | Protein levels | Pancreatic epithelium | 24 | 0 | 3 | 5 | |
| 662 | CLEC11A levels | PROLV000445 | 3.88 | Protein levels | Hematopoietic progenitor | 65 | 3 | 5 | 10 | |
| 663 | PLXNB2 levels | PROLV001586 | 3.87 | Protein levels | Hepatocyte | 124 | 2 | 6 | 21 | |
| 664 | CD74/NPDC1 ratio | PRORT000506 | 3.86 | Protein ratios | Lymphocyte | 43 | 3 | 22 | 25 | |
| 665 | Digital deformity | MSKEL000053 | 3.85 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 666 | Ventricular mass | CARDI000012 | 3.85 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 667 | BANK1/FOXO1 ratio | PRORT000204 | 3.85 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 668 | DNMBP/WWP2 ratio | PRORT000934 | 3.85 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 669 | CD40/IGSF8 ratio | PRORT000444 | 3.84 | Protein ratios | Muscle / cardiac | 5 | 6 | 9 | 20 | |
| 670 | Papulosquamous disorder | DERMA000015 | 3.83 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 671 | BST2 levels | PROLV000216 | 3.83 | Protein levels | Myeloid | 103 | 2 | 6 | 18 | |
| 672 | Seborrhoeic dermatitis | DERMA000020 | 3.83 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 673 | GLB1 levels | PROLV000894 | 3.82 | Protein levels | Hepatocyte | 103 | 4 | 10 | 19 | |
| 674 | CCS levels | PROLV000307 | 3.82 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 675 | DIPK2B levels | PROLV000619 | 3.82 | Protein levels | Vascular | 85 | 4 | 10 | 22 | |
| 676 | CNTNAP4 levels | PROLV000481 | 3.82 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 677 | CCL5/CXCL3 ratio | PRORT000355 | 3.81 | Protein ratios | Muscle / cardiac | 6 | 2 | 7 | 14 | |
| 678 | Dermatitis and eczema | DERMA000008 | 3.81 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 679 | CA13/TYMP ratio | PRORT000273 | 3.80 | Protein ratios | Myeloid | 6 | 2 | 7 | 7 | |
| 680 | TIGIT levels | PROLV002034 | 3.80 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 681 | LCN2/S100A12 ratio | PRORT001444 | 3.79 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 682 | Dizziness and giddiness | AUDIO000020 | 3.78 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 683 | CD86 levels | PROLV000360 | 3.77 | Protein levels | Myeloid | 72 | 5 | 16 | 20 | |
| 684 | PTPRR levels | PROLV001680 | 3.77 | Protein levels | Epithelial | 0 | 0 | 7 | 15 | |
| 685 | Financial satisfaction | SOCIO000024 | 3.76 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 686 | CD79B/ICAM3 ratio | PRORT000512 | 3.76 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 687 | Personality disorder | PSYCH000035 | 3.76 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 688 | FABP1/LGALS4 ratio | PRORT001095 | 3.75 | Protein ratios | Hepatocyte | 27 | 1 | 9 | 21 | |
| 689 | Plant sterols | METAB000074 | 3.75 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 690 | ITGB1BP2/MITD1 ratio | PRORT001385 | 3.75 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 691 | CACNA2D3 levels | PROLV000250 | 3.74 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 692 | LAT/LYN ratio | PRORT001422 | 3.73 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 693 | IRAG2/TBC1D23 ratio | PRORT001367 | 3.73 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 694 | TXNL1 levels | PROLV002126 | 3.72 | Protein levels | Lymphocyte | 35 | 2 | 13 | 14 | |
| 695 | Family history, chronic lung disease | RESPI000002 | 3.71 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 696 | FAS levels | PROLV000770 | 3.70 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 697 | Narcolepsy | NEURO000036 | 3.70 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 698 | CKAP4/LAMP3 ratio | PRORT000621 | 3.70 | Protein ratios | Epithelial | 36 | 0 | 9 | 11 | |
| 699 | ENO2/RWDD1 ratio | PRORT001029 | 3.70 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 700 | Allergic rhinitis | IMMUN000004 | 3.69 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 701 | Coeliac disease | IMMUN000026 | 3.69 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 702 | LBR/PSRC1 ratio | PRORT001440 | 3.69 | Protein ratios | Myeloid | 1 | 4 | 10 | 15 | |
| 703 | STK24/TDRKH ratio | PRORT001820 | 3.68 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 704 | Non-cancer illness burden | MISCL000029 | 3.66 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 705 | TNFRSF8 levels | PROLV002073 | 3.66 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 706 | Respiratory disease | RESPI000004 | 3.66 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 707 | Disability allowance, none | SOCIO000016 | 3.65 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 708 | LAMP3 levels | PROLV001182 | 3.65 | Protein levels | Myeloid | 82 | 2 | 10 | 20 | |
| 709 | PLXNA4/SRPK2 ratio | PRORT001686 | 3.64 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 710 | Lipid unsaturation | LIPID000079 | 3.64 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 711 | Erythrocyte | HEMAT000005 | 3.64 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 712 | Snack and fast-food preference | DTSUP000017 | 3.63 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 713 | CPXM1/SPARC ratio | PRORT000736 | 3.63 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 714 | MGLL/STK4 ratio | PRORT001531 | 3.62 | Protein ratios | Hepatocyte | 36 | 1 | 7 | 15 | |
| 715 | Pneumonia | IMMUN000069 | 3.62 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 716 | Cancer, Thyroid | MALIG000032 | 3.62 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 717 | CEACAM8/RNASE3 ratio | PRORT000589 | 3.62 | Protein ratios | Hematopoietic progenitor | 2 | 3 | 4 | 11 | |
| 718 | Ventricular function | CARDI000008 | 3.61 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 719 | Alcohol use | PSYCH000043 | 3.60 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 720 | MEGF10 levels | PROLV001293 | 3.59 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 721 | OSM/TGFA ratio | PRORT001617 | 3.59 | Protein ratios | Myeloid | 11 | 2 | 11 | 22 | |
| 722 | Circadian timing | BEHAV000014 | 3.59 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 723 | CPQ levels | PROLV000509 | 3.59 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 724 | CD163/FOLR2 ratio | PRORT000380 | 3.59 | Protein ratios | Myeloid | 56 | 4 | 12 | 18 | |
| 725 | IL3RA levels | PROLV001074 | 3.59 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 726 | GZMA/TNFRSF4 ratio | PRORT001261 | 3.59 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 727 | RFC4 levels | PROLV001726 | 3.58 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 728 | ARL13B levels | PROLV000143 | 3.58 | Protein levels | Stromal / connective | 0 | 1 | 5 | 10 | |
| 729 | CLEC4D/CLEC6A ratio | PRORT000654 | 3.57 | Protein ratios | Lymphocyte | 4 | 3 | 13 | 35 | |
| 730 | Polyamine metabolites | METAB000059 | 3.56 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 731 | ENO2/HCLS1 ratio | PRORT001023 | 3.55 | Protein ratios | Myeloid | 13 | 2 | 11 | 16 | |
| 732 | EPCAM levels | PROLV000715 | 3.55 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 733 | PPP2R2A levels | PROLV001618 | 3.55 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 734 | AHSP/HMBS ratio | PRORT000058 | 3.54 | Protein ratios | Lymphocyte | 33 | 4 | 16 | 48 | |
| 735 | Substance use | PSYCH000049 | 3.53 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 736 | MZB1 levels | PROLV001366 | 3.52 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 737 | AXL/CD163 ratio | PRORT000178 | 3.52 | Protein ratios | Myeloid | 19 | 4 | 18 | 33 | |
| 738 | PPP1R2/TBL1X ratio | PRORT001706 | 3.51 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 739 | NOTCH1 levels | PROLV001416 | 3.50 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 740 | HGF/MMP9 ratio | PRORT001283 | 3.49 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 28 | |
| 741 | Excessive sweating | DERMA000029 | 3.49 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 742 | BTN3A2 levels | PROLV000220 | 3.49 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 743 | Smoking dependency | PSYCH000047 | 3.48 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 744 | FOLR2/MSR1 ratio | PRORT001169 | 3.47 | Protein ratios | Myeloid | 40 | 2 | 10 | 11 | |
| 745 | GSTA1/KRT18 ratio | PRORT001249 | 3.46 | Protein ratios | Hepatocyte | 13 | 2 | 7 | 12 | |
| 746 | TMEM25 levels | PROLV002047 | 3.46 | Protein levels | Hepatocyte | 24 | 1 | 5 | 19 | |
| 747 | GNLY levels | PROLV000905 | 3.46 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 748 | HAVCR2 levels | PROLV000954 | 3.46 | Protein levels | Myeloid | 31 | 0 | 3 | 11 | |
| 749 | ALPP levels | PROLV000083 | 3.45 | Protein levels | Respiratory epithelium | 12 | 0 | 11 | 19 | |
| 750 | BCL2L2 levels | PROLV000189 | 3.44 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 751 | Asthma | IMMUN000005 | 3.43 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 752 | Prospective memory | PSYCH000009 | 3.42 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 753 | WNT9A levels | PROLV002194 | 3.42 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 754 | CXCL5/MESD ratio | PRORT000828 | 3.42 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 755 | Biliverdin | HPBIL000018 | 3.42 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 756 | Implantable cardioverter-defibrillator | CARDI000050 | 3.41 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 757 | Upper respiratory tract disease | RESPI000042 | 3.41 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 758 | AXIN1/SRPK2 ratio | PRORT000177 | 3.41 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 759 | FLT3/FLT3LG ratio | PRORT001165 | 3.40 | Protein ratios | Lymphocyte | 5 | 5 | 11 | 30 | |
| 760 | CD74/JAM2 ratio | PRORT000504 | 3.40 | Protein ratios | Myeloid | 51 | 4 | 10 | 17 | |
| 761 | ST6GAL1 levels | PROLV001953 | 3.40 | Protein levels | Myeloid | 81 | 3 | 11 | 16 | |
| 762 | Gut microbial abundance, Staphylococcus | GASTR000036 | 3.39 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 763 | Risk-taking behaviour | BEHAV000013 | 3.39 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 764 | CA14 levels | PROLV000243 | 3.39 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 765 | AKT1S1/TDRKH ratio | PRORT000066 | 3.38 | Protein ratios | Stromal / connective | 0 | 3 | 9 | 28 | |
| 766 | RARRES2/ST6GAL1 ratio | PRORT001727 | 3.38 | Protein ratios | Myeloid | 42 | 1 | 6 | 8 | |
| 767 | SCARF2/TNFRSF21 ratio | PRORT001763 | 3.35 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 768 | TSPAN1 levels | PROLV002115 | 3.35 | Protein levels | Myeloid | 19 | 1 | 8 | 10 | |
| 769 | KL levels | PROLV001147 | 3.35 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 770 | APOF levels | PROLV000125 | 3.35 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 771 | RGMB/TNFRSF21 ratio | PRORT001739 | 3.35 | Protein ratios | Myeloid | 17 | 3 | 12 | 30 | |
| 772 | Respiratory symptom | RESPI000032 | 3.35 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 773 | Gestational hypertension | VASCU000045 | 3.35 | Vascular | Lymphocyte | 3 | 1 | 7 | 22 | |
| 774 | Aplastic anaemia | HEMAT000004 | 3.35 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 775 | PSRC1/SORT1 ratio | PRORT001715 | 3.34 | Protein ratios | Myeloid | 2 | 3 | 10 | 11 | |
| 776 | Heart rate response to exercise | CARDI000025 | 3.34 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 777 | CEACAM8 levels | PROLV000394 | 3.33 | Protein levels | Myeloid | 75 | 2 | 11 | 14 | |
| 778 | PDCD1/TNFRSF4 ratio | PRORT001629 | 3.33 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 779 | CRKL/MANF ratio | PRORT000764 | 3.33 | Protein ratios | Myeloid | 5 | 4 | 13 | 18 | |
| 780 | C1S levels | PROLV000229 | 3.33 | Protein levels | Myeloid | 0 | 3 | 14 | 17 | |
| 781 | SOD2 levels | PROLV001917 | 3.33 | Protein levels | Myeloid | 96 | 2 | 6 | 7 | |
| 782 | HTRA2/SIAE ratio | PRORT001311 | 3.33 | Protein ratios | Lymphocyte | 8 | 5 | 13 | 32 | |
| 783 | CD160/KLRB1 ratio | PRORT000377 | 3.32 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 784 | CD8A levels | PROLV000361 | 3.31 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 785 | Clonal haematopoiesis | HEMAT000015 | 3.31 | Hematologic | Myeloid | 54 | 2 | 3 | 15 | |
| 786 | BSG/LAMP3 ratio | PRORT000248 | 3.31 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 787 | MGLL/MITD1 ratio | PRORT001527 | 3.30 | Protein ratios | Hepatocyte | 42 | 3 | 11 | 16 | |
| 788 | CD109 levels | PROLV000309 | 3.29 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 789 | Vitreous disorder | OPHTH000047 | 3.29 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 790 | EPCAM/GPA33 ratio | PRORT001035 | 3.29 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 791 | CTSZ levels | PROLV000570 | 3.29 | Protein levels | Hepatocyte | 81 | 1 | 7 | 12 | |
| 792 | IFNAR1 levels | PROLV001018 | 3.27 | Protein levels | Myeloid | 52 | 4 | 11 | 23 | |
| 793 | SLC51B levels | PROLV001883 | 3.27 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 794 | Non-cancer illness history | MISCL000030 | 3.27 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 795 | Oral health conditions, none | DENTA000009 | 3.26 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 796 | HLA-A levels | PROLV000972 | 3.25 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 797 | GPC1 levels | PROLV000919 | 3.24 | Protein levels | Muscle / cardiac | 104 | 2 | 6 | 8 | |
| 798 | CD55/ITGB1 ratio | PRORT000470 | 3.24 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 799 | FADD/PPP1R2 ratio | PRORT001109 | 3.24 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 800 | REG1A/REG3A ratio | PRORT001729 | 3.23 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 801 | PAMR1 levels | PROLV001493 | 3.23 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 802 | CDH17/SPINT1 ratio | PRORT000551 | 3.23 | Protein ratios | Lymphocyte | 11 | 1 | 12 | 15 | |
| 803 | DXO levels | PROLV000665 | 3.22 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 804 | CD79B/FCRL2 ratio | PRORT000511 | 3.22 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 805 | BCR/GOPC ratio | PRORT000225 | 3.21 | Protein ratios | Hepatocyte | 4 | 3 | 10 | 33 | |
| 806 | SNX18 levels | PROLV001912 | 3.21 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 807 | GLT25D1 levels | PROLV000899 | 3.20 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 808 | IL15/NCR1 ratio | PRORT001344 | 3.19 | Protein ratios | Lymphocyte | 32 | 2 | 9 | 31 | |
| 809 | CXCL9 levels | PROLV000587 | 3.19 | Protein levels | Lymphocyte | 72 | 2 | 13 | 32 | |
| 810 | FLT3LG levels | PROLV000817 | 3.19 | Protein levels | Hematopoietic progenitor | 69 | 3 | 7 | 12 | |
| 811 | CTF1/ITGB1BP2 ratio | PRORT000793 | 3.19 | Protein ratios | Hematopoietic progenitor | 18 | 4 | 10 | 21 | |
| 812 | Negative affect | PSYCH000030 | 3.19 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 813 | Taste preference | DTSUP000023 | 3.18 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 814 | CCL18 levels | PROLV000284 | 3.17 | Protein levels | Myeloid | 16 | 3 | 9 | 15 | |
| 815 | Cardiac pacemaker | CARDI000049 | 3.17 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 816 | Biliary cirrhosis | HPBIL000005 | 3.16 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 817 | RIDA levels | PROLV001733 | 3.16 | Protein levels | Hepatocyte | 51 | 3 | 17 | 29 | |
| 818 | Telomere length | AGING000001 | 3.15 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 819 | Study participation | BEHAV000004 | 3.15 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 820 | ENO2/TACC3 ratio | PRORT001032 | 3.15 | Protein ratios | Myeloid | 9 | 3 | 6 | 20 | |
| 821 | IDO1 levels | PROLV001011 | 3.14 | Protein levels | Myeloid | 66 | 2 | 11 | 32 | |
| 822 | Transport mode | BEHAV000009 | 3.12 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 823 | LYN/SIRT2 ratio | PRORT001472 | 3.11 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 824 | Medication, anti-malarial | IMMUN000083 | 3.11 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 825 | Chronic respiratory disease | RESPI000003 | 3.11 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 826 | FIS1/HSPA1A ratio | PRORT001149 | 3.11 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 827 | Legume preference | DTSUP000014 | 3.11 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 828 | CDKN1A/DAB2 ratio | PRORT000565 | 3.10 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 27 | |
| 829 | PXN levels | PROLV001688 | 3.10 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 830 | OMD/SPP1 ratio | PRORT001615 | 3.10 | Protein ratios | Hepatocyte | 9 | 3 | 10 | 20 | |
| 831 | BMP10 levels | PROLV000202 | 3.09 | Protein levels | Myeloid | 97 | 2 | 8 | 17 | |
| 832 | SCARA3 levels | PROLV001779 | 3.09 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 833 | SLAMF7/TXNDC15 ratio | PRORT001789 | 3.08 | Protein ratios | Hepatocyte | 28 | 3 | 11 | 24 | |
| 834 | CREG1 levels | PROLV000517 | 3.08 | Protein levels | Hepatocyte | 128 | 2 | 13 | 21 | |
| 835 | Hearing aid use | AUDIO000011 | 3.08 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 836 | Otitis media | AUDIO000017 | 3.07 | Auditory | Myeloid | 33 | 0 | 2 | 4 | |
| 837 | AXL levels | PROLV000167 | 3.06 | Protein levels | Myeloid | 83 | 4 | 14 | 44 | |
| 838 | PCOLCE levels | PROLV001510 | 3.06 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 839 | Methionine metabolites | METAB000010 | 3.05 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 840 | Connective tissue disorder | MSKEL000060 | 3.05 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 841 | Autoimmune polyglandular syndrome | IMMUN000025 | 3.04 | Immunologic | Hepatocyte | 0 | 1 | 10 | 25 | |
| 842 | CPA2/ITGB7 ratio | PRORT000723 | 3.04 | Protein ratios | Hepatocyte | 53 | 1 | 11 | 16 | |
| 843 | CRH levels | PROLV000520 | 3.04 | Protein levels | Hematopoietic progenitor | 35 | 1 | 1 | 7 | |
| 844 | Prurigo | DERMA000017 | 3.03 | Dermatologic | Lymphocyte | 1 | 2 | 8 | 29 | |
| 845 | ACP5 levels | PROLV000014 | 3.02 | Protein levels | Myeloid | 150 | 2 | 11 | 22 | |
| 846 | CLK2 levels | PROLV000460 | 3.02 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 847 | TNFSF12 levels | PROLV002077 | 3.01 | Protein levels | Lymphocyte | 61 | 2 | 7 | 31 | |
| 848 | Heart failure, congestive | CARDI000004 | 3.00 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 849 | IBD-Ulcerative colitis | IMMUN000031 | 2.99 | Immunologic | Myeloid | 239 | 2 | 12 | 28 | |
| 850 | Depression | PSYCH000024 | 2.98 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 851 | VCAM1 levels | PROLV002155 | 2.97 | Protein levels | Myeloid | 128 | 2 | 6 | 10 | |
| 852 | Other ear disorder | AUDIO000004 | 2.96 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 853 | Dietary pattern | DTSUP000007 | 2.95 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 854 | Electronic device use | BEHAV000017 | 2.95 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 855 | PROK1 levels | PROLV001638 | 2.93 | Protein levels | Myeloid | 74 | 2 | 15 | 17 | |
| 856 | Chest pain | CARDI000052 | 2.93 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 857 | BAX/MAX ratio | PRORT000205 | 2.93 | Protein ratios | Myeloid | 0 | 2 | 7 | 12 | |
| 858 | IFNLR1 levels | PROLV001022 | 2.93 | Protein levels | Hepatocyte | 49 | 2 | 7 | 19 | |
| 859 | CHMP1A/EREG ratio | PRORT000612 | 2.93 | Protein ratios | Myeloid | 33 | 3 | 14 | 21 | |
| 860 | MICB or MICA levels | PROLV001312 | 2.93 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 861 | PRL levels | PROLV001635 | 2.93 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 862 | CXCL5/SDC4 ratio | PRORT000831 | 2.93 | Protein ratios | Myeloid | 4 | 3 | 7 | 9 | |
| 863 | FCRLB levels | PROLV000788 | 2.91 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 864 | DKK1/VEGFC ratio | PRORT000905 | 2.91 | Protein ratios | Muscle / cardiac | 10 | 1 | 7 | 12 | |
| 865 | DAB2/GRAP2 ratio | PRORT000838 | 2.90 | Protein ratios | Myeloid | 11 | 4 | 9 | 17 | |
| 866 | Diabetes, type 1 | IMMUN000012 | 2.90 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 867 | CUZD1 levels | PROLV000571 | 2.90 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 868 | ITGB1BP2/LAT2 ratio | PRORT001383 | 2.89 | Protein ratios | Platelet | 15 | 1 | 6 | 15 | |
| 869 | CRTAM/FCRL6 ratio | PRORT000768 | 2.89 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 870 | Occupation | SOCIO000006 | 2.89 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 871 | FGF21 levels | PROLV000795 | 2.88 | Protein levels | Hepatocyte | 41 | 2 | 4 | 5 | |
| 872 | PCDH1/TNFRSF11A ratio | PRORT001623 | 2.88 | Protein ratios | Myeloid | 1 | 1 | 4 | 11 | |
| 873 | IGFBP7 levels | PROLV001033 | 2.88 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 874 | EPHB6/LAYN ratio | PRORT001037 | 2.87 | Protein ratios | Muscle / cardiac | 6 | 2 | 3 | 13 | |
| 875 | PTPRS levels | PROLV001681 | 2.87 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 876 | PRG3 levels | PROLV001629 | 2.87 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 877 | SIGLEC6 levels | PROLV001862 | 2.87 | Protein levels | Myeloid | 115 | 2 | 5 | 11 | |
| 878 | ITGB1BP2/TIA1 ratio | PRORT001389 | 2.86 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 879 | White matter volume | NIMAG000028 | 2.86 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 880 | CD74/DLL1 ratio | PRORT000502 | 2.85 | Protein ratios | Vascular | 48 | 2 | 13 | 37 | |
| 881 | LBR/MAD1L1 ratio | PRORT001438 | 2.85 | Protein ratios | Myeloid | 0 | 3 | 10 | 24 | |
| 882 | Medication use | MISCL000037 | 2.85 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 883 | PRG2 levels | PROLV001628 | 2.84 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 884 | CD163/DSC2 ratio | PRORT000379 | 2.84 | Protein ratios | Hepatocyte | 19 | 3 | 14 | 13 | |
| 885 | Bleeding gums | DENTA000011 | 2.84 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 886 | CTSD levels | PROLV000562 | 2.83 | Protein levels | Myeloid | 103 | 3 | 12 | 12 | |
| 887 | DOK2/GRAP2 ratio | PRORT000938 | 2.83 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 888 | SCG3 levels | PROLV001785 | 2.83 | Protein levels | Vascular | 110 | 0 | 8 | 11 | |
| 889 | ANXA3/ENO2 ratio | PRORT000106 | 2.82 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 6 | 13 | |
| 890 | VNN1 levels | PROLV002164 | 2.82 | Protein levels | Hepatocyte | 55 | 3 | 12 | 25 | |
| 891 | DCTN1/TRIAP1 ratio | PRORT000874 | 2.82 | Protein ratios | Myeloid | 0 | 4 | 16 | 31 | |
| 892 | WFDC5 levels | PROLV002190 | 2.82 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 893 | IPCEF1/TBCB ratio | PRORT001364 | 2.81 | Protein ratios | Stromal / connective | 2 | 3 | 5 | 5 | |
| 894 | CEACAM8/VNN2 ratio | PRORT000590 | 2.79 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 895 | DRG2/SEMA4D ratio | PRORT000949 | 2.78 | Protein ratios | Hepatocyte | 6 | 3 | 17 | 35 | |
| 896 | CDH17/PTPRM ratio | PRORT000550 | 2.78 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 897 | LY96/ST6GAL1 ratio | PRORT001471 | 2.78 | Protein ratios | Hepatocyte | 11 | 3 | 7 | 10 | |
| 898 | ALCAM levels | PROLV000078 | 2.76 | Protein levels | Hepatocyte | 193 | 3 | 13 | 31 | |
| 899 | Latent factor, red cell | HEMAT000038 | 2.75 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 900 | ATRN levels | PROLV000163 | 2.75 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 901 | CD300E levels | PROLV000331 | 2.75 | Protein levels | Myeloid | 202 | 2 | 7 | 8 | |
| 902 | Membranous nephropathy | NEPHR000008 | 2.74 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 903 | Urinary system disorder | NEPHR000005 | 2.74 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 904 | ENO2/FXYD5 ratio | PRORT001022 | 2.74 | Protein ratios | Myeloid | 4 | 5 | 13 | 27 | |
| 905 | COVID-19 | IMMUN000054 | 2.74 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 906 | PSAP levels | PROLV001653 | 2.73 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 907 | DBNL/VASH1 ratio | PRORT000869 | 2.73 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 908 | Deafness with mutism | AUDIO000010 | 2.72 | Auditory | Hepatocyte | 0 | 1 | 9 | 18 | |
| 909 | Raynaud phenomenon | VASCU000060 | 2.72 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 910 | ARSA/GUSB ratio | PRORT000143 | 2.72 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 911 | Fruit preference | DTSUP000012 | 2.71 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 912 | Memory disorder | PSYCH000006 | 2.71 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 913 | Vitamin B12 deficiency anaemia | HEMAT000014 | 2.70 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 914 | GET3 levels | PROLV000873 | 2.70 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 915 | Sleep apnoea | RESPI000035 | 2.69 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 916 | FCRL6/KLRD1 ratio | PRORT001138 | 2.69 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 917 | EPHB6/TNFRSF9 ratio | PRORT001038 | 2.68 | Protein ratios | Myeloid | 23 | 3 | 15 | 47 | |
| 918 | ATP5IF1/HSPA1A ratio | PRORT000158 | 2.68 | Protein ratios | Myeloid | 21 | 3 | 7 | 15 | |
| 919 | CR1 levels | PROLV000513 | 2.68 | Protein levels | Myeloid | 140 | 3 | 10 | 17 | |
| 920 | CST3/TAFA5 ratio | PRORT000787 | 2.67 | Protein ratios | Myeloid | 1 | 3 | 10 | 9 | |
| 921 | SNRPB2 levels | PROLV001910 | 2.65 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 922 | FCRL6/GZMA ratio | PRORT001137 | 2.65 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 923 | CD163/IL18BP ratio | PRORT000382 | 2.65 | Protein ratios | Myeloid | 12 | 2 | 11 | 20 | |
| 924 | CCL18/RARRES2 ratio | PRORT000348 | 2.65 | Protein ratios | Myeloid | 8 | 2 | 10 | 15 | |
| 925 | ELOA/MAD1L1 ratio | PRORT001015 | 2.65 | Protein ratios | Myeloid | 4 | 3 | 9 | 15 | |
| 926 | Subcortical volume | NIMAG000026 | 2.65 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 927 | SNAP23/TBL1X ratio | PRORT001794 | 2.64 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 928 | VSTM2B levels | PROLV002175 | 2.64 | Protein levels | Lymphocyte | — | 3 | 16 | 34 | |
| 929 | SIRT1 levels | PROLV001869 | 2.63 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 930 | CD164/NUDT5 ratio | PRORT000388 | 2.63 | Protein ratios | Myeloid | 6 | 3 | 8 | 10 | |
| 931 | SNAP25 levels | PROLV001906 | 2.63 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 932 | Wheeze | RESPI000034 | 2.63 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 933 | Cancer, Cervix | MALIG000012 | 2.63 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 934 | PDGFA/USP8 ratio | PRORT001638 | 2.63 | Protein ratios | Myeloid | 3 | 4 | 16 | 26 | |
| 935 | CLEC7A levels | PROLV000457 | 2.62 | Protein levels | Myeloid | 64 | 1 | 5 | 15 | |
| 936 | Coffee preference | DTSUP000002 | 2.61 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 937 | MUC2 levels | PROLV001353 | 2.61 | Protein levels | B / plasma cell | 35 | 0 | 6 | 8 | |
| 938 | CLSTN3 levels | PROLV000465 | 2.60 | Protein levels | Hepatocyte | 53 | 1 | 5 | 15 | |
| 939 | CFC1 levels | PROLV000411 | 2.60 | Protein levels | Hematopoietic progenitor | 4 | 1 | 3 | 5 | |
| 940 | DCXR/GSTA1 ratio | PRORT000876 | 2.60 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 941 | Colonic and urogenital fistula | GASTR000010 | 2.59 | Gastrointestinal | Lymphocyte | 1 | 1 | 3 | 18 | |
| 942 | ITGAM/ITGAV ratio | PRORT001375 | 2.59 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 943 | ADGRE5/ITGB2 ratio | PRORT000031 | 2.59 | Protein ratios | Myeloid | 75 | 4 | 11 | 15 | |
| 944 | ENO3 levels | PROLV000707 | 2.59 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 945 | Immune cell marker, Monocyte | HEMAT000027 | 2.59 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 946 | Insulin sensitivity | METBL000042 | 2.58 | Metabolic | Myeloid | 1 | 1 | 3 | 8 | |
| 947 | ATP5IF1/METAP1D ratio | PRORT000160 | 2.58 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 948 | Benign neoplasm, Ocular | MALIG000005 | 2.57 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 949 | CST3/CTSZ ratio | PRORT000780 | 2.57 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 14 | |
| 950 | Refractive errors | OPHTH000034 | 2.57 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 951 | Cancer, Skin | MALIG000028 | 2.57 | Malignancy | Lymphocyte | 302 | 3 | 14 | 19 | |
| 952 | Psoriatic arthritis | IMMUN000040 | 2.57 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 953 | Adhesive capsulitis | MSKEL000058 | 2.57 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 954 | Cirrhosis | HPBIL000006 | 2.56 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 955 | Water consumption | DTSUP000004 | 2.56 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 956 | DDAH1 levels | PROLV000607 | 2.55 | Protein levels | Myeloid | 3 | 7 | 10 | 19 | |
| 957 | Tryptophan metabolites | METAB000015 | 2.55 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 958 | Dietary preference | DTSUP000008 | 2.54 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 959 | Carotid intima-media thickness | VASCU000053 | 2.54 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 960 | Digestive system symptoms | GASTR000044 | 2.54 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 961 | NAP1L4 levels | PROLV001374 | 2.53 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 962 | PRTN3/RETN ratio | PRORT001711 | 2.53 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 963 | CRYGD levels | PROLV000534 | 2.52 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 964 | Birth complication | REPRO000036 | 2.52 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 965 | CFB levels | PROLV000410 | 2.51 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 966 | CDNF levels | PROLV000384 | 2.50 | Protein levels | Myeloid | 4 | 3 | 9 | 9 | |
| 967 | SNAP29/VEGFC ratio | PRORT001800 | 2.50 | Protein ratios | Lymphocyte | 5 | 2 | 8 | 38 | |
| 968 | Cancer, Respiratory system | MALIG000027 | 2.49 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 969 | TPI1 levels | PROLV002093 | 2.49 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 970 | Family history, chronic disease | MISCL000009 | 2.49 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 971 | EBAG9/TGFB1 ratio | PRORT000963 | 2.48 | Protein ratios | Myeloid | 11 | 4 | 18 | 48 | |
| 972 | MMP9/PLTP ratio | PRORT001549 | 2.48 | Protein ratios | Myeloid | 15 | 4 | 15 | 30 | |
| 973 | THOP1 levels | PROLV002028 | 2.48 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 974 | CSNK2A1 or CSNK2B levels | PROLV000545 | 2.48 | Protein levels | B / plasma cell | 1 | 0 | 8 | 5 | |
| 975 | MCEE levels | PROLV001284 | 2.47 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 976 | CCL13/CCL17 ratio | PRORT000337 | 2.47 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 977 | AXIN1/NFATC1 ratio | PRORT000176 | 2.47 | Protein ratios | Muscle / cardiac | 2 | 2 | 8 | 17 | |
| 978 | IFNG levels | PROLV001019 | 2.47 | Protein levels | Lymphocyte | 30 | 3 | 11 | 38 | |
| 979 | Wellbeing | PSYCH000056 | 2.45 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 980 | PPP1R14D levels | PROLV001615 | 2.45 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 981 | ICAM2/SELE ratio | PRORT001325 | 2.45 | Protein ratios | Granulosa cell | 0 | 2 | 5 | 17 | |
| 982 | PEAR1/PECAM1 ratio | PRORT001657 | 2.45 | Protein ratios | Myeloid | 24 | 3 | 15 | 24 | |
| 983 | CXCL5/SPARC ratio | PRORT000833 | 2.45 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 984 | TTN levels | PROLV002119 | 2.45 | Protein levels | Muscle / cardiac | 13 | 2 | 10 | 23 | |
| 985 | Ceramides | LIPID000065 | 2.44 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 986 | CD83 levels | PROLV000358 | 2.44 | Protein levels | Myeloid | 197 | 2 | 7 | 10 | |
| 987 | Nucleoside metabolites | METAB000061 | 2.44 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 988 | Operation, gastrointestinal | GASTR000039 | 2.44 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 989 | CD5 levels | PROLV000344 | 2.44 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 990 | EGFL7 levels | PROLV000685 | 2.44 | Protein levels | Lymphocyte | 31 | 2 | 7 | 25 | |
| 991 | Catecholamine metabolites | METAB000070 | 2.43 | Metabolites | Vascular | 0 | 1 | 3 | 6 | |
| 992 | PCDH9 levels | PROLV001508 | 2.43 | Protein levels | Myeloid | 32 | 2 | 9 | 15 | |
| 993 | Urinary metabolite ratio | METAB000057 | 2.43 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 994 | Mononeuropathy | NEURO000027 | 2.43 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 995 | APEX1/LSP1 ratio | PRORT000116 | 2.43 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 996 | CD83/LAMP3 ratio | PRORT000517 | 2.42 | Protein ratios | Myeloid | 31 | 2 | 8 | 7 | |
| 997 | GNLY/GZMA ratio | PRORT001221 | 2.42 | Protein ratios | Lymphocyte | 41 | 3 | 18 | 47 | |
| 998 | Ventricular volume | CARDI000015 | 2.42 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 999 | TNFSF8 levels | PROLV002081 | 2.42 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 1000 | RAB31 levels | PROLV001699 | 2.41 | Protein levels | Lymphocyte | 0 | 3 | 6 | 14 |